← Back to Search

BRCA-Gist for Breast and Ovarian Cancer

N/A

Waitlist Available

Led By Alejandra H Hurtado de Mendoza, PhD

Research Sponsored by Georgetown University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within one hour before the intervention and within one hour post-intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial will test an intervention to improve cancer outcomes in Latina and Black women by increasing their participation in genetic cancer risk assessments.

Eligible Conditions

Breast and Ovarian Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within one hour before the intervention and within one hour post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within one hour before the intervention and within one hour post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and within one hour before the intervention and within one hour post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Breast Cancer Genetics Knowledge

Intentions to participate in genetic counseling

Perceived pros and cons of genetic counseling and testing

Secondary study objectives

Declarative Knowledge of Breast Cancer, Genetic Testing, and Genetic Risk

Emotions about developing breast cancer and about participating in genetic counseling

Malignant Neoplasms

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Immediate BRCA-Gist InterventionExperimental Treatment1 Intervention

Participants randomized to immediate BRCA-gist will complete the adapted intervention and immediately complete a baseline survey. They will be asked to complete a second survey two weeks after completion of the first one. BRCA-gist is a web-based tutoring system that emulates one-to-one human tutoring via avatars to communicate risk of BRCA1/2. We estimate a completion time of 90 minutes.

Group II: Delayed BRCA-Gist InterventionExperimental Treatment1 Intervention

Participants randomized to delayed BRCA-gist will initially complete a baseline survey. Two weeks after completion of that survey, they will complete the adapted intervention and immediately complete a second survey.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

BRCA-Gist

2017

N/A

~100

Do I qualify?Apply below to find out